Viewing Study NCT00201669


Ignite Creation Date: 2025-12-24 @ 10:52 PM
Ignite Modification Date: 2025-12-25 @ 8:21 PM
Study NCT ID: NCT00201669
Status: COMPLETED
Last Update Posted: 2017-12-06
First Post: 2005-09-12
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: A Phase II Study of Clofarabine in Patients With Aggressive Non-Hodgkin's Lymphoma
Sponsor: Ohio State University Comprehensive Cancer Center
Organization:

Key Dates - Follows AllAPIJSON File Order

Start Date: 2004-10
Start Date Type: None
Primary Completion Date: 2006-05
Primary Completion Date Type: ACTUAL
Completion Date: 2006-06
Completion Date Type: ACTUAL
First Submit Date: 2005-09-12
First Submit QC Date: None
Study First Post Date: 2005-09-20
Study First Post Date Type: ESTIMATED
Results First Submit Date: None
Results First Submit QC Date: None
Results First Post Date: None
Results First Post Date Type: None
Results First Post QC Date: None
Results First Post QC Date Type: None
Disp First Submit Date: None
Disp First Submit QC Date: None
Disp First Post Date: None
Disp First Post Date Type: None
Last Update Submit Date: 2017-12-04
Last Update Post Date: 2017-12-06
Last Update Post Date Type: ACTUAL